Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86


Population-based screening in the era of genomics.

Pashayan N, Pharoah P.

Per Med. 2012 Jun;9(4):451-455.


Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.

Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, Easton DF, Eeles R, Pharoah P.

Br J Cancer. 2011 May 10;104(10):1656-63. doi: 10.1038/bjc.2011.118. Epub 2011 Apr 5.


Public health genomics and personalized prevention: lessons from the COGS project.

Pashayan N, Hall A, Chowdhury S, Dent T, Pharoah PD, Burton H.

J Intern Med. 2013 Nov;274(5):451-6. doi: 10.1111/joim.12094.


How can polygenic inheritance be used in population screening for common diseases?

Khoury MJ, Janssens AC, Ransohoff DF.

Genet Med. 2013 Jun;15(6):437-43. doi: 10.1038/gim.2012.182. Epub 2013 Feb 14. Review.


Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues.

Hall AE, Chowdhury S, Hallowell N, Pashayan N, Dent T, Pharoah P, Burton H.

J Public Health (Oxf). 2014 Jun;36(2):285-91. doi: 10.1093/pubmed/fdt078. Epub 2013 Aug 28. Review.


Incorporating genomics into breast and prostate cancer screening: assessing the implications.

Chowdhury S, Dent T, Pashayan N, Hall A, Lyratzopoulos G, Hallowell N, Hall P, Pharoah P, Burton H.

Genet Med. 2013 Jun;15(6):423-32. doi: 10.1038/gim.2012.167. Epub 2013 Feb 14. Review.


Implications of polygenic risk for personalised colorectal cancer screening.

Frampton MJ, Law P, Litchfield K, Morris EJ, Kerr D, Turnbull C, Tomlinson IP, Houlston RS.

Ann Oncol. 2016 Mar;27(3):429-34. doi: 10.1093/annonc/mdv540. Epub 2015 Nov 16.


The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer.

Hawken SJ, Greenwood CM, Hudson TJ, Kustra R, McLaughlin J, Yang Q, Zanke BW, Little J.

Hum Genet. 2010 Jul;128(1):89-101. doi: 10.1007/s00439-010-0828-1. Epub 2010 May 1.


Stratified cancer screening: the practicalities of implementation.

Dent T, Jbilou J, Rafi I, Segnan N, Törnberg S, Chowdhury S, Hall A, Lyratzopoulos G, Eeles R, Eccles D, Hallowell N, Pashayan N, Pharoah P, Burton H.

Public Health Genomics. 2013;16(3):94-9. doi: 10.1159/000345941. Epub 2013 Jan 26.


Ability to predict breast cancer in Asian women using a polygenic susceptibility model.

Hartman M, Suo C, Lim WY, Miao H, Teo YY, Chia KS.

Breast Cancer Res Treat. 2011 Jun;127(3):805-12. doi: 10.1007/s10549-010-1279-z. Epub 2010 Dec 14.


Prostate cancer screening using risk stratification based on a multi-state model of genetic variants.

Yen AM, Auvinen A, Schleutker J, Wu YY, Fann JC, Tammela T, Chen SL, Chiu SY, Chen HH.

Prostate. 2015 Jun;75(8):825-35. doi: 10.1002/pros.22964. Epub 2015 Feb 14.


Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling?

Chowdhury S, Henneman L, Dent T, Hall A, Burton A, Pharoah P, Pashayan N, Burton H.

J Pers Med. 2015 Jun 9;5(2):191-212. doi: 10.3390/jpm5020191. Review.


Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis.

Pashayan N, Duffy SW, Neal DE, Hamdy FC, Donovan JL, Martin RM, Harrington P, Benlloch S, Amin Al Olama A, Shah M, Kote-Jarai Z, Easton DF, Eeles R, Pharoah PD.

Genet Med. 2015 Oct;17(10):789-95. doi: 10.1038/gim.2014.192. Epub 2015 Jan 8.


Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.

Colditz GA.

Crit Rev Food Sci Nutr. 2010;50 Suppl 1:10-2. doi: 10.1080/10408398.2010.526838.


False-negative results in screening programmes: systematic review of impact and implications.

Petticrew MP, Sowden AJ, Lister-Sharp D, Wright K.

Health Technol Assess. 2000;4(5):1-120. Review.


Genetic susceptibility, predicting risk and preventing cancer.

Pharoah PD.

Recent Results Cancer Res. 2003;163:7-18; discussion 264-6. Review.


Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.

Darabi H, Czene K, Zhao W, Liu J, Hall P, Humphreys K.

Breast Cancer Res. 2012 Feb 7;14(1):R25.


Conceptual issues for screening in the genomic era - time for an update?

Wright CF, Zimmern RL.

Epidemiol Biostat Public Health. 2014 Dec 11;11(4). pii: e9944.


'A low risk is still a risk': exploring women's attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention.

Henneman L, Timmermans DR, Bouwman CM, Cornel MC, Meijers-Heijboer H.

Public Health Genomics. 2011;14(4-5):238-47. doi: 10.1159/000276543. Epub 2010 Jan 14.


Supplemental Content

Support Center